SCHEMBL31482124

SCHEMBL31482124

O=C(O)c1ccc(-c2ccc(CCl)cc2)nc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LDHA P00338 3/20 0.65
▸ NPC1 O15118 4/20 0.63
▸ RAB9A P51151 3/20 0.63
▸ SMN1; SMN2 Q16637 3/20 0.63
▸ TP53 P04637 1/20 0.60
▸ P4HA1 P13674 3/20 0.59
▸ P4HTM Q9NXG6 2/20 0.59
▸ NFKB1 P19838 1/20 0.56
▸ NFKB2 Q00653 1/20 0.56
▸ RELA Q04206 1/20 0.56
▸ ADRB1 P08588 1/20 0.48
▸ ADRB3 P13945 1/20 0.48
▸ HPGDS O60760 1/20 0.48
▸ RXFP1 Q9HBX9 2/20 0.47
▸ NAPRT Q6XQN6 1/20 0.47
▸ BAZ2B Q9UIF8 1/20 0.45
▸ ADH5 P11766 1/20 0.45
▸ MIF P14174 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3169338 0.87 NPC1 (0.51) LDHANPC1RAB9ASMN1; SMN2TP53
SCHEMBL8521766 0.86 LDHA (0.85) LDHANPC1RAB9ASMN1; SMN2TP53
SCHEMBL5592910 0.85 LDHA (0.67) LDHANPC1RAB9ASMN1; SMN2TP53
SCHEMBL30753641 0.84 LDHA (0.81) LDHANPC1RAB9ASMN1; SMN2TP53
SCHEMBL28312333 0.84 LDHA (0.81) LDHANPC1RAB9ASMN1; SMN2TP53
SCHEMBL5648046 0.81 LDHA (0.71) LDHANPC1RAB9ASMN1; SMN2TP53
SCHEMBL28060317 0.80 LDHA (0.73) LDHANPC1RAB9ASMN1; SMN2TP53
SCHEMBL505455 0.79 LDHA (1.00) LDHANPC1RAB9ASMN1; SMN2TP53
SCHEMBL24975547 0.78 LDHA (0.71) LDHANPC1RAB9ASMN1; SMN2TP53
SCHEMBL2947695 0.78 NPC1 (0.75) LDHANPC1RAB9ASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025080049-A1 COMPOUND FOR INHIBITING ATX, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTING OR TREATING ATX ACTIVITY-RELATED DISEASES CONTAINING SAME AS ACTIVE INGREDIENT 한국화학연구원 2025-04-17 — — WO disclosed
Send feedback